As previously described, the Oncomine database pinpointed a significant downregulation of LZTS1 mRNA expression in breast cancer samples (p<0.001), which was further confirmed by immunohistochemistry in a series of 270 breast cancers and 16 normal breast specimens. This evidence concerns the gene LZTS1 and breast carcinoma.